Literature DB >> 9682007

Heparin, but not other proteoglycans potentiates the mitogenic effects of FGF-2 on mesencephalic precursor cells.

M A Caldwell1, C N Svendsen.   

Abstract

There is increasing evidence that the proteoglycan heparin plays a critical role in the regulation of the activity of FGF-2 by either interacting with its receptor or modifying its stability and functioning. In this study precursor cells were isolated from the rat E14 ventral mesencephalon and cultured as free floating spheres in FGF-2 alone or in combination with heparin or other related proteoglycans, including chondroitin sulfate, keratin sulfate, dermatan sulfate, or hyaluronic acid. Our results show the mitogenic effects of FGF-2 could be potentiated by heparin but not the other four proteoglycans. Sodium chlorate, which blocks the cells ability to sulfate its proteoglycans, was shown to reduce the mitogenic effects of FGF-2 alone to below that of control levels, suggesting that endogenous sulfated molecules are required for the FGF-2 effects on mesencephalic precursors. Cells expanded for 7 days with either FGF-2 or FGF-2 + heparin were plated onto a substrate and allowed to differentiate for a further 7 days in the absence of growth factors. Approximately 6% of the precursors developed into neurons whether grown with or without heparin and none were positive for TH, a marker for dopamine neurons. However, there was a significant decrease in the number of astrocytes developing from cultures grown in FGF-2 + heparin when compared to FGF-2 alone. Interestingly we could not find an EGF responsive cell in the mesencephalon at this embryonic age in the absence or presence of heparin. However, there was a synergistic effect of combining EGF + FGF-2, which could be potentiated by heparin. We conclude that heparin, but not other closely related proteoglycans, is vital for the growth of FGF-2-responsive mesencephalic neural precursors. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9682007     DOI: 10.1006/exnr.1998.6815

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  13 in total

1.  Basic fibroblast growth factor (bFGF) facilitates differentiation of adult dorsal root ganglia-derived neural stem cells toward Schwann cells by binding to FGFR-1 through MAPK/ERK activation.

Authors:  Yun Gu; Chenbin Xue; Jianbin Zhu; Hualin Sun; Fei Ding; Zheng Cao; Xiaosong Gu
Journal:  J Mol Neurosci       Date:  2013-09-27       Impact factor: 3.444

Review 2.  Neurodegeneration and cell replacement.

Authors:  Brandi K Ormerod; Theo D Palmer; Maeve A Caldwell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

3.  Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth.

Authors:  Michael Fannon; Kimberly Forsten-Williams; Matthew A Nugent; Kalvin J Gregory; Chia Lin Chu; Adrienne L Goerges-Wildt; Dipak Panigrahy; Arja Kaipainen; Carmen Barnes; Cathy Lapp; Yuen Shing
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

4.  Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI.

Authors:  Philip J Johnson; Alexander Tatara; Alicia Shiu; Shelly E Sakiyama-Elbert
Journal:  Cell Transplant       Date:  2009-10-09       Impact factor: 4.064

5.  Retentive multipotency of adult dorsal root ganglia stem cells.

Authors:  Rabindra P Singh; Ying-Hua Cheng; Paul Nelson; Feng C Zhou
Journal:  Cell Transplant       Date:  2009       Impact factor: 4.064

6.  In vitro growth and differentiation of canine olfactory bulb-derived neural progenitor cells under variable culture conditions.

Authors:  Raquel M Walton; John H Wolfe
Journal:  J Neurosci Methods       Date:  2007-12-27       Impact factor: 2.390

7.  In vitro and in vivo enhanced generation of human A9 dopamine neurons from neural stem cells by Bcl-XL.

Authors:  Elise T Courtois; Claudia G Castillo; Emma G Seiz; Milagros Ramos; Carlos Bueno; Isabel Liste; Alberto Martínez-Serrano
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

Review 8.  FGF2: a novel druggable target for glioblastoma?

Authors:  Ana Jimenez-Pascual; Kelly Mitchell; Florian A Siebzehnrubl; Justin D Lathia
Journal:  Expert Opin Ther Targets       Date:  2020-03-16       Impact factor: 6.797

9.  The necessity for standardization of glioma stem cell culture: a systematic review.

Authors:  Lei Zhang; Hongwei Yu; Yuhui Yuan; John S Yu; Zhenkun Lou; Yixue Xue; Yunhui Liu
Journal:  Stem Cell Res Ther       Date:  2020-02-26       Impact factor: 6.832

Review 10.  Midbrain dopaminergic neuron fate specification: Of mice and embryonic stem cells.

Authors:  Emily Gale; Meng Li
Journal:  Mol Brain       Date:  2008-09-30       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.